We are a provider-focused wound care partner, offering advanced biologics, conservative-to-advanced treatment solutions, and compliance-ready documentation to support physicians and facilities nationwide.

In many cases, Medicare Part B and certain Advantage plans may cover amniotic tissue grafts and wound care services when deemed medically necessary. Coverage depends on the patient’s plan, provider documentation, and medical guidelines.

Our solutions are designed for providers treating chronic, diabetic, vascular, burn, surgical, and infected wounds. We also support healthcare facilities seeking reliable wound care partnerships to improve outcomes and efficiency.

Doctors and facilities can contact us directly through our website or phone. Our team will guide you through the partnership process and ensure seamless integration into your workflow.

No. While based in Atlanta, our reach extends across the nation, supporting providers wherever wound care solutions are needed.

We combine advanced biologics, trusted protocols, and compliance-focused documentation to give providers measurable results in healing, efficiency, and reputation.

Contact our team to discuss partnership opportunities. We provide dedicated wound care expertise, reliable product supply, and ongoing support for practices and facilities.

A biologic graft derived from the placenta’s innermost layer. Rich in growth factors and anti-inflammatory properties, it supports tissue repair, accelerates healing, and reduces scarring in chronic wounds.

Yes. Amniotic tissue is FDA-regulated, processed under strict safety standards, and applied topically in-office. It’s non-invasive and widely used across multiple specialties.

No. Amniotic membrane grafts are applied in-office by the provider. It’s minimally invasive and easily integrated into wound care regimens.

Results vary, but many providers see wound improvements in weeks. Chronic wounds unresponsive to standard treatments may show significant healing progress with consistent applications.

Your team conducts the evaluation. Patients with chronic or non-healing wounds who haven’t responded to standard care are often strong candidates.